ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $4,759,000 | -79.4% | 37,200 | -81.9% | 0.01% | -78.3% |
Q3 2020 | $23,092,000 | +78.7% | 205,207 | +51.3% | 0.02% | +109.1% |
Q2 2020 | $12,919,000 | -28.0% | 135,600 | -32.1% | 0.01% | -35.3% |
Q1 2020 | $17,938,000 | +760.3% | 199,600 | +246.5% | 0.02% | +325.0% |
Q3 2016 | $2,085,000 | +2.5% | 57,600 | -10.4% | 0.00% | -20.0% |
Q2 2015 | $2,034,000 | – | 64,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 1,505,012 | $204,095,000 | 39.96% |
Foresite Capital Management III, LLC | 108,630 | $14,731,000 | 12.94% |
Avoro Capital Advisors LLC | 3,000,000 | $406,830,000 | 7.03% |
Octagon Capital Advisors LP | 112,363 | $15,238,000 | 5.74% |
Artal Group S.A. | 1,400,000 | $189,854,000 | 3.36% |
Eversept Partners, LP | 241,981 | $32,815,043 | 2.47% |
NWI MANAGEMENT LP | 200,000 | $27,122,000 | 2.26% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,500 | $8,199,000 | 2.17% |
Affinity Asset Advisors, LLC | 45,000 | $6,102,000 | 2.07% |
Parkman Healthcare Partners LLC | 62,780 | $8,514,000 | 1.98% |